Physician

Internal Medicine

Doctor Jacob D. Soumerai, MD is an expert in the field of Internal Medicine. He studied medicine at Tufts University School of Medicine. Tufts University School of Medicine is ranked 49 in research and 52 in primary care medicine He received awards:"Inductee". Jacob Soumerai is a published MD. He has 17 publications published. The most current publication "Diagnosis and management of castleman disease."

Publications

---

• Diagnosis and management of castleman disease.
• Treatment of primary mediastinal B-cell Lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary re...
• Long-term follow-up of symptomatic patients with lymphoplasmacytic Lymphoma/Waldenstrom macroglobulinemia treated with the anti-CD52 monoclonal antibody alemtuzumab.
• Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
• Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
• Comparative outcomes following CP-R, CVP-R, and CHOP-R in Waldenström's macroglobulinemia.
• Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.
• CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.
• Thalidomide and rituximab in Waldenstrom macroglobulinemia.
• Novel agents in the treatment of Waldenström's macroglobulinemia.
• The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia.
• Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia.
• Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
• Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia.
• Hepatitis C viral infection is not associated with Waldenström's macroglobulinemia.
• Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy.

Schools

---

• Tufts University

Conditions Treated

---

• Lymphoma
• Mycosis Fungoides

Doctors Specialties

---

• Hematology
• Internal Medicine

Accepted Insurances

---

Awards

---

• Inductee

Education

---

• Massachusetts General Hospital
• Tufts University School of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Brett J. Carroll, MD This Doctor is OpenDoctor Recommended.
	Dr. Adrienne Gropper, MD This Doctor is OpenDoctor Recommended.
	Dr. Nishan Tchekmedyian, MD
	Dr. Brendan D. McNulty, MD This Doctor is OpenDoctor Recommended.
	Dr. Ann H. Partridge, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah Nikiforow, MD This Doctor is OpenDoctor Recommended.
	Dr. Omar Amir, MD This Doctor is OpenDoctor Recommended.
	Dr. Lauren Rothkopf, MD
	Dr. Maki Aoki, MD This Doctor is OpenDoctor Recommended.
	Dr. Claude I. Alabre, MD This Doctor is OpenDoctor Recommended.
	Dr. Julia Hsu, MD This Doctor is OpenDoctor Recommended.
	Dr. Srila Gopal, MD This Doctor is OpenDoctor Recommended.
	Dr. Nameeta M. Dookeran, MD This Doctor is OpenDoctor Recommended.
	Dr. Harvey J. Makadon, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Helen A. Leibner, MD This Doctor is OpenDoctor Recommended.
	Dr. Jatin K. Dave, MD This Doctor is OpenDoctor Recommended.
	Dr. Pengwynne P. Blevins, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard Saitz, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog